Ascendis Pharma A/SASNDNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$51.77M
↑ 122% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-237.67M
Historical baseline
PeriodValueYoY Change
2025$51.77M+116.9%
2024$-306.20M+34.5%
2023$-467.36M+5.7%
2022$-495.70M-18.7%
2021$-417.65M-53.8%
2020$-271.55M-54.3%
2019$-175.94M-26.8%
2018$-138.80M-46.0%
2017$-95.10M-58.0%
2016$-60.18M-